On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope
FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 20, 2023 – USA News Group – Earlier this year, the US White House requested over $2.8 billion in funding from Congress for their “Cancer Moonshot” initiative, an ambitious plan to slash cancer rates in half within the next quarter-century. Already, […]
Rapidly Increasing Demand for Solar Energy Booming Creating a Multi-Billion Dollar Market Opportunity
Palm Beach, FL – September 20, 2023 – FinancialNewsMedia.com News Commentary – Electricity demand worldwide is growing rapidly because of economic progress and population growth. The rising level of lifestyle and the expansion of infrastructure are driving up demand for power generation. As a result, most countries are building new solar plants or upgrading old ones to […]
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
NetworkNewsWire Editorial Coverage New York, NY – September 20, 2023 – More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the development and evaluation of new treatments, particularly for rare diseases, is a key priority for the U.S. Food & […]
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise
Palm Beach, FL – September 20, 2023 – FinancialNewsMedia.com News Commentary – The demand for abuse deterrent formulation technology is projected to grow due to growing misuse of drugs among the people. Growing demand for abuse deterrent formulation technology from the pharmaceutical industry is driving the market growth. Abuse-deterrent formulations are used to decrease the […]
Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology
Patent issuance expands U.S. patent portfolio for AVERSA™ transdermal abuse deterrent technology Orlando, FL – September 20, 2023 – Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that the United States Patent and Trademark Office (USPTO) has granted US Patent No. 11,759,431 for Nutriband’s proprietary AVERSA™ abuse deterrent technology utilizing […]
SolarBank Completes Sale of 21MW Community Solar Sites in Upstate New York to Honeywell International
Total transaction value is US$41 million Projects are construction ready and SolarBank will act as EPC Contractor Expected to operate as community solar sites, selling credits to subscribers Expected to be eligible to participate in the NYSUN program to receive NYSERDA incentives Toronto – SolarBank Corporation (CSE: SUNN) (OTC: SUUNF) (FSE: GY2) (“SolarBank” or […]
